GKOS
GLAUKOS Corp
Key Financials
Operating Income
$-199600000
↓ 63.1%
Gross Profit
$282.8M
↓ 2.3%
Net Income
$-187691000
↓ 28.2%
EPS (Diluted)
$-3.28
↓ 18.4%
Total Assets
$893.5M
↓ 8.3%
Total Liabilities
$237.3M
↑ 14.2%
Cash & Equivalents
$90.8M
↓ 46.5%
Shareholders' Equity
$656.2M
↓ 14.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 144 | 5/14/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 144 | 5/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GKOS |
| Company Name | GLAUKOS Corp |
| CIK | 1192448 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-367-9600 |